F

Fresenius Medical Care

Operates dialysis facilities and renal care

Regulatory Intelligence and Operational Excellence Lead

Full-TimePosted on 10/22/2026Deadline 2/28/27
No salary listed
Expert
Bachelor's
Bengaluru, Karnataka, India
HybridHybrid work setup; office located in Hebbal, Bengaluru.
Biology & BiotechRegulatory & Quality (Life Sciences)

About the job

Requirements
  • A bachelor's degree or higher in Pharmacy, Life Sciences, Chemistry, Biochemistry, or a related scientific discipline.
  • 12–18 years of experience in regulatory affairs, regulatory intelligence, or a closely related function in the pharmaceutical or biotechnology industry.
  • Demonstrated experience monitoring and synthesizing global regulatory agency guidance, including FDA, EMA, ICH, and others, with scientific literacy to interpret complex regulatory documents and dossier requirements.
  • Experience with SOP governance, onboarding or training coordination, POA tracking, or continuous improvement.
  • Proficiency in building and maintaining SharePoint, Teams, RIMS, or similar regulatory knowledge-management platforms.
  • High proficiency in written and spoken English.
  • Experience working in a global matrix across time zones and building trust across functions and geographies without direct authority.
  • Exposure to NDA, MAA, or equivalent submissions.
Responsibilities
  • Own the regulatory intelligence and knowledge-sharing framework for Global Drug Regulatory Affairs, linking global, regional, and Local RA teams.
  • Monitor health authority guidance, ICH guidelines, inspection trends, and competitor approvals relevant to CC Products, PD Solutions, and Renal Pharma.
  • Prepare intelligence briefs and reports that turn external and internal information into actionable insights for GDRA leadership and stakeholders.
  • Capture internal learnings from health authority interactions, approvals, labeling, and inspections in a searchable knowledge base.
  • Enable two-way intelligence exchange with Local RA and regional teams, and define when learnings warrant broader communication.
  • Own the intelligence process, including intake, assessment, dissemination, and feedback, using standard templates and reporting cadences.
  • Coordinate GDRA SOP harmonization and lifecycle with process owners, including review schedules, version control, change communication, and training.
  • Map and improve cross-functional regulatory workflows, and use inspection observations and feedback to support root-cause assessment.
  • Design, coordinate, and improve GDRA onboarding programs, checklists, and completion tracking.
  • Coordinate LDRA process activities and develop training with local and global regulatory colleagues.
  • Administer POA review cycles and action tracking, and escalate overdue items.
  • Maintain dashboards for SOPs, onboarding, LDRA training, POA actions, and improvements; report progress and risks to the Head of Renal Pharma, Operational Excellence and Regulatory Intelligence.
  • Partner with RA Operations to integrate intelligence into RIMS and GDRA platforms, support due diligence, and manage external sources such as Citeline and RAPS.
Desired Qualifications
  • Experience in a GBS or shared services environment.
  • Background in CMC, labeling, or nonclinical work.

About the company

F

Fresenius Medical Care

View

Fresenius Medical Care North America runs a network of dialysis facilities and outpatient labs to deliver coordinated kidney care for hundreds of thousands of patients. It also offers specialty pharmacy and laboratory services and manufactures a wide range of dialysis equipment, disposables, and renal drugs. The company treats patients by providing dialysis and related care at its clinics, supported by the equipment, supplies, and medicines it develops and distributes. FMCNA differentiates itself through its size and integration as the world's largest fully integrated renal company, with a nationwide network covering care delivery, drugs, labs, and manufacturing, aiming to provide high-quality, convenient access to comprehensive services across North America.

Company Size

11-50

Company Stage

Late Stage VC

Total Funding

$40.2M

Headquarters

Waltham, Massachusetts

Founded

1996

Get referred to Fresenius Medical Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 operating income rose 23%, showing transformation gains reached profitability.
  • FME25+ delivered EUR 67 million savings in Q2 2026 and targets EUR 1.2 billion.
  • Real-world evidence studies in July and August 2026 strengthen high-volume hemodiafiltration adoption.

What critics are saying

  • The August 2026 outlook disappointed investors after dialysis growth stalled and shares fell 10%.
  • FME25+ closed around 100 U.S. clinics in 2026, risking patient leakage to DaVita.
  • AB 290 litigation and premium-assistance rules threaten U.S. reimbursement economics and legal spend.

What makes Fresenius Medical Care unique

  • Fresenius Medical Care controls dialysis care, equipment, labs, and specialty pharmacy end-to-end.
  • Its 5008X CAREsystem reached around 100 clinics and 100,000 treatments by May 2026.
  • kinexus and TherapyWise deepen its software moat across home dialysis and kidney therapy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget
  • Conference Attendance Budget
  • Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
Business Wire
Mar 28th, 2024
Compsych Corporation Announces 2023 Health At Work Award Winners

CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Dec 6th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Home Health Provider
Feb 17th, 2023
Improving Access & Timely Care For Vulnerable Patients Referred To Home Health Via Telehealth Physician Support

Royal Philips (NYSE: PHG AEX: PHIA), a global leader in health technology, today announced the debut of its eCareManager 4.1 enterprise telehealth software at the American Telemedicine...